Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C

This study has been terminated.
(Dose levels were determined to be subtherapeutic)
Sponsor:
Information provided by (Responsible Party):
Valeant Pharmaceuticals International, Inc.
ClinicalTrials.gov Identifier:
NCT00305383
First received: March 17, 2006
Last updated: June 21, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2007
  Estimated Primary Completion Date: No date given